In the INDI-UTI study, eligible children were between 3 months and 12 years of age, were febrile (≥38°C) at the time of or within 24 hours preceding the start of treatment, and had growth of ...

Immunization programs save millions of lives every year by protecting against preventable diseases. The immune response to ...

As the United States faces one of its worst measles outbreaks in decades, a new analysis finds that nearly a third of young ...

BioMarin BMRN has announced positive results from the phase III PEGASUS study evaluating Palynziq (pegvaliase) in adolescents aged 12-17 years with phenylketonuria (PKU). The study achieved its ...

The global quest to prevent childhood cancer deaths has a long history. For decades, efforts have centred on driving innovation to produce more effective therapies, improve understanding in how and ...

At All Doses Evaluated, VAX-24 Was Well-Tolerated and Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20® (PCV20) -- -- At ...

"This is a great example of a vaccine that protects against invasive disease from a bacteria we see causing infections every ...

There were 23 matches for internal medicine. You can find the number matches and their programs below: 17 - family medicine 15 - pediatrics 8 - obstetrics 8 - gynecology Among this year's class ...

The agency's email said ACIP workgroups have continued to meet and will present at the rescheduled April 15-16 meeting. The spokesman said the meeting will include a measles update and the full ...

Officials recommend that children get their first dose of the measles-mumps-rubella (MMR) vaccine between 12 and 15 months of age ... to Dr. Christina Johns, a pediatric emergency physician ...